ALTIRIS THERAPEUTICS
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
ALTIRIS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Total Employee:
501+
Status:
Active
Contact:
(404) 537-4961
Total Funding:
46.34 M USD
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
ATDC
ATDC investment in Venture Round - Altiris Therapeutics
ATDC
ATDC investment in Series C - Altiris Therapeutics
ATDC
ATDC investment in Series B - Altiris Therapeutics
Georgia Venture Partners
Georgia Venture Partners investment in Series B - Altiris Therapeutics
Centrosome Ventures
Centrosome Ventures investment in Series B - Altiris Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Altiris Therapeutics
Talu Ventures
Talu Ventures investment in Series B - Altiris Therapeutics
H.I.G. Capital
H.I.G. Capital investment in Series B - Altiris Therapeutics
SR One
SR One investment in Series B - Altiris Therapeutics
MedImmune Ventures
MedImmune Ventures investment in Series B - Altiris Therapeutics